Semaglutide in weight management

Affiliations

¹ Department of Nephrology, The Second Xiangya Hospital, Central South University, Changsha 410011, China.
² Department of Nephrology, The Second Xiangya Hospital, Central South University, Changsha 410011, China. Electronic address: sunlin@csu.edu.cn.

Comment

Ying Xiao et al. Lancet. 2019.

. 2019 Oct 5;394(10205):1226.

doi: 10.1016/S0140-6736(18)33195-7.

¹ Department of Nephrology, The Second Xiangya Hospital, Central South University, Changsha 410011, China.
² Department of Nephrology, The Second Xiangya Hospital, Central South University, Changsha 410011, China. Electronic address: sunlin@csu.edu.cn.

No abstract available

Comment in

Semaglutide in weight management - Author's reply.
Wilding JPH. Wilding JPH. Lancet. 2019 Oct 5;394(10205):1226-1227. doi: 10.1016/S0140-6736(19)31904-X. Lancet. 2019. PMID: 31591978 No abstract available.

Efficacy and safety of semaglutide compared with liraglutide and placebo for weight loss in patients with obesity: a randomised, double-blind, placebo and active controlled, dose-ranging, phase 2 trial.
O'Neil PM, Birkenfeld AL, McGowan B, Mosenzon O, Pedersen SD, Wharton S, Carson CG, Jepsen CH, Kabisch M, Wilding JPH. O'Neil PM, et al. Lancet. 2018 Aug 25;392(10148):637-649. doi: 10.1016/S0140-6736(18)31773-2. Epub 2018 Aug 16. Lancet. 2018. PMID: 30122305 Clinical Trial.